NCT01982383

Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

A Prospective Study of the Use of Micropulse 577nm Laser Treatment in Central Serous Chorioretinopathy

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: George Washington University · Academic / Other
• Sex: All
• Age: 30 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.

Detailed description

The investigators hypothesize that application of 577nm micropulse laser in patients with CSC will prompt resolution of CSC as measured by ocular coherence tomography and best corrected visual acuity. This will be a pilot study to establish sound methods and provide some insights to the safety and efficacy of CSC treatment.

Conditions

• Central Serous Chorioretinopathy

Interventions

Type	Name	Description
DEVICE	Micropulse Laser Treatment
OTHER	No treatment

Timeline

• Start date: 2012-11-01
• Primary completion: 2015-11-01
• Completion: 2015-11-01
• First posted: 2013-11-13
• Last updated: 2018-03-27
• Results posted: 2018-03-27

Locations

1 site across 1 country: United States